Follow-The-Filings

Security · featured owners

PGNY Progyny Inc.

Health Care COM Equity as of 2026 Q2 among managers we track

  • 1 Owner
  • Max 0.0%
  • $6M
  • 1 add 1 exit

PGNY (Progyny Inc.) is held in 1 featured 13F book as of 2026 Q2. First Eagle Investment Management is the largest tracked holder by portfolio weight (0.01%). Figures are as-filed 13F, not free float.

Who owns this now

Largest portfolio weights among featured holders · max 0.0% (First Eagle Investment Management) · not free-float ownership

  1. First Eagle Investment Manage... Add 0.01%

Holders

sorted by value · long equity only · current book 2026 Q2 · open a manager for their book

History
First Eagle Investment Management 2026 Q2 0.01% Add +8.4% 213,212 $6M History
Farallon Capital Management exited 2026 Q2 Last 2026 Q1 <0.01% Exit 0.00% 18,000 $306K History

1 current · 1 exited last period · options excluded

SEC filings

Recent issuer filings from EDGAR · 8 shown · open Filing / Doc on SEC.gov

Filed Form Detail Links
10-Q Filing Doc
8-K 2.02,7.01 Filing Doc
8-K 5.03,5.07 Filing Doc
8-K 8.01 Filing Doc
10-Q Filing Doc
8-K 2.02,7.01 Filing Doc
DEFA14A Filing Doc
8-K 8.01 Filing Doc

Insider forms

Form 3 / 4 / 5 from EDGAR · 17 rows shown

Filed Form Detail Links
4 Period Sep 23, 2026 Filing Doc
4 Period Sep 17, 2026 Filing Doc
4/A Period Sep 10, 2026 Filing Doc
4 Period Sep 10, 2026 Filing Doc
4 Period Sep 4, 2026 Filing Doc
4 Period Sep 3, 2026 · 2 forms Filing Doc
4 Period Sep 2, 2026 Filing Doc
4 Period Aug 28, 2026 Filing Doc
4 Period Jul 14, 2026 Filing Doc
4 Period Jun 17, 2026 Filing Doc
4 Period Jun 3, 2026 · 3 forms Filing Doc
4 Period Jun 2, 2026 Filing Doc
4 Period Jun 1, 2026 Filing Doc
4 Period Jun 2, 2026 Filing Doc
4 Period May 28, 2026 Filing Doc
4 Period May 27, 2026 Filing Doc
4 Period May 21, 2026 · 6 forms Filing Doc

Updated 1 day ago Source: SEC EDGAR submissions All on EDGAR

Financials

US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing

Income statement

Metric FY2023 FY2024 FY2025
Revenue $1.09B $1.17B $1.29B
Gross profit $238.8M $253.36M $304.48M
Gross margin * 21.9% 21.7% 23.6%
Net income $62.04M $54.34M $58.52M
Net margin * 5.7% 4.7% 4.5%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $640.41M $472.72M $551.78M
Total non-current assets * $116.21M $134.38M $190.66M
Total assets $756.62M $607.1M $742.44M
Total current liabilities $185.95M $168.63M $202.39M
Total non-current liabilities * $17.24M $16.41M $24M
Total equity $553.43M $422.06M $516.04M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations $188.81M $179.1M $210.19M
Cash from investing -$200.52M $195.79M -$159.01M
Cash from financing -$11.07M -$309.88M -$99.36M
Net change in cash -$22.78M $65.02M -$48.12M

Source: SEC companyfacts (US-GAAP 10-K) · * = computed (not a single XBRL tag) · fiscal year as labeled by the issuer · not adjusted or audited by Follow-The-Filings

Ownership over time

filing count by report period · click a bar for that quarter’s holders